SCHEMBL1126706

SCHEMBL1126706

CCOC(=O)c1[nH]c(C)c(C(=O)OCC)c1-c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.62
HTT P42858 3/20 0.62
NPSR1 Q6W5P4 2/20 0.62
RXFP1 Q9HBX9 1/20 0.62
NPC1 O15118 9/20 0.61
RAB9A P51151 9/20 0.61
KMT2A Q03164 3/20 0.61
CASP3 P42574 1/20 0.59
SENP8 Q96LD8 1/20 0.59
SENP7 Q9BQF6 1/20 0.59
SENP6 Q9GZR1 1/20 0.59
LMNA P02545 5/20 0.58
SMN1; SMN2 Q16637 5/20 0.58
MAPT P10636 5/20 0.58
HPGD P15428 4/20 0.58
KDM4E B2RXH2 2/20 0.58
GAA P10253 2/20 0.58
XBP1 P17861 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C19 P33261 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24584793 0.93 ALDH1A1 (0.56) ALDH1A1HTTNPSR1RXFP1NPC1
SCHEMBL29757646 0.92 RAB9A (0.56) ALDH1A1HTTNPSR1RXFP1NPC1
SCHEMBL31567903 0.88 LMNA (0.72) ALDH1A1HTTNPSR1RXFP1NPC1
SCHEMBL31567898 0.88 LMNA (0.72) ALDH1A1HTTNPSR1RXFP1NPC1
SCHEMBL21480114 0.87 CYP1A2 (0.58) ALDH1A1HTTNPSR1RXFP1NPC1
SCHEMBL95163 0.86 ALDH1A1 (0.62) ALDH1A1HTTNPSR1RXFP1NPC1
SCHEMBL24584761 0.86 NPC1 (0.63) ALDH1A1HTTNPSR1RXFP1NPC1
SCHEMBL1126748 0.86 ALDH1A1 (0.56) ALDH1A1HTTNPSR1RXFP1NPC1
SCHEMBL31567904 0.85 ALDH1A1 (0.62) ALDH1A1HTTNPSR1RXFP1NPC1
SCHEMBL31567905 0.85 ALDH1A1 (0.62) ALDH1A1HTTNPSR1RXFP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12497397-B2 Pyrrole compounds useful as antifungals Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2025-12-16 US disclosed
EP-4071137-B1 NOVEL PYRROLE COMPOUND WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN) 2025-10-15 EP disclosed
US-20240327423-A1 A SERIES OF PYRROLE DERIVATIVES AND THEIR PREPARATION METHOD AND THERAPEUTIC USE Shenzhen Sungening Biological Co., Ltd (CN) 2024-10-03 US disclosed
US-11819503-B2 Method of treating coccidioides infection F2G LTD (GB) 2023-11-21 US disclosed
US-11819503-B2 Method of treating coccidioides infection F2G LTD (GB) 2023-11-21 US disclosed
US-11819503-B2 Method of treating coccidioides infection F2G LTD (GB) 2023-11-21 US disclosed
EP-4265621-A1 PYRROLE DERIVATIVE, AND PREPARATION METHOD AND USE THEREFOR Shenzhen Sungening Bio-Medical Co., Ltd. (CN) 2023-10-25 EP disclosed
CN-109982704-B Pharmaceutical preparation F2G有限公司 2023-10-24 CN disclosed
CN-114206836-B Novel pyrrole compounds 微境生物医药科技(上海)有限公司 2023-10-13 CN disclosed
CN-116675704-A Pyrrole derivative and preparation method and application thereof 深圳市祥根生物医药有限公司 2023-09-01 CN disclosed
WO-2016079536-A1 ANTIFUNGAL AGENTS F2G LIMITED (GB) 2016-05-26 WO disclosed
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-08-27 US disclosed
US-8993574-B2 Pyrrole antifungal agents F2G LTD (GB) 2015-03-31 US disclosed
EP-2283006-B1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-02-25 EP disclosed
EP-2626361-B1 Pyrrole antifungal agents F2G LTD (GB) 2014-10-15 EP disclosed
EP-2626361-A1 Pyrrole antifungal agents F2G Limited (GB) 2013-08-14 EP disclosed
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2011-06-23 US disclosed
EP-2283006-A1 PYRROLE ANTIFUNGAL AGENTS F2G Limited (GB) 2011-02-16 EP disclosed
WO-2009130481-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2009-10-29 WO disclosed
WO-2003035614-A2 TYROSINE KINASE INHIBITORS MERCK & CO., INC. (US) 2003-05-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327423-A1 A SERIES OF PYRROLE DERIVATIVES AND THEIR PREPARATION METHOD AND THERAPEUTIC USE DHODH, PPOX, HPD ALDH1A1 575/4885HTT 946/4885NPSR1 2703/4885
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 ALDH1A1 219/4885HTT 776/4885NPSR1 227/4885
US-12497397-B2 Pyrrole compounds useful as antifungals PYCR1, CYP51A1, DPM1 ALDH1A1 1752/4885HTT 2893/4885NPSR1 1160/4885
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 ALDH1A1 219/4885HTT 776/4885NPSR1 227/4885
US-11819503-B2 Method of treating coccidioides infection DPM1, OAT, OTC ALDH1A1 415/4885HTT 4808/4885NPSR1 2481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.